Support Alert

Class 4 Medicines Notification: Fresenius Kabi Limited, Sodium Chloride Intravenous Infusion 0.9% Freeflex

Fresenius Kabi Limited has informed the Medicines and Healthcare products Regulatory Agency (MHRA) of an error on the infusion bag packaged into the specific batches of Sodium Chloride Intravenous Infusion 0.9% Freeflex.

Further information, advice and details of the affected batches can be found on the MHRA website.


Email newsletter

Want the latest pharmacy news and updates straight to your inbox?

Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.

Sign Up